RSS feed

Publications by Anders Erik Astrup Dahm

66 publications found

Original articles

Theocharides A, Gisslinger H, De Stefano V, Accurso V, Iurlo A, Devos T, Egyed M, Lippert E, Delgado RG, Cantoni N, Dahm AEA, Sotiropoulos D, Houtsma E, Smyth A, Iqbal A, Di Matteo P, Zuurman M, Te Boekhorst PAW (2023)
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study
Eur J Haematol, 112 (3), 379-391
DOI 10.1111/ejh.14124, PubMed 37899734

Hussaini P, Larsen TL, Ghanima W, Dahm AEA (2023)
Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism
Thromb Haemost, 124 (4), 351-362
DOI 10.1055/a-2188-8773, PubMed 37816388

Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
Arterial events in cancer patients treated with apixaban for venous thrombosis
Thromb Res, 228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527

Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
J Thromb Haemost, 20 (5), 1166-1181
DOI 10.1111/jth.15666, PubMed 35114046

Dalen V, Vegsgaard Olsen AS, Jerome CP, Geitung JT, Dahm AEA (2021)
Low diagnostic accuracy and inter-observer agreement on CT and MRI in diagnosis of spinal fractures in multiple myeloma
Hematol Rep, 13 (3), 9037
DOI 10.4081/hr.2021.9037, PubMed 34733448

Khialani D, Vasan S, Cushman M, Dahm AEA, Sandset PM, Rossouw J, van Hylckama Vlieg A (2021)
Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor
J Thromb Haemost, 19 (7), 1729-1737
DOI 10.1111/jth.15319, PubMed 33774921

Cui XY, Tjønnfjord GE, Kanse SM, Dahm AEA, Iversen N, Myklebust CF, Sun L, Jiang ZX, Ueland T, Campbell JJ, Ho M, Sandset PM (2021)
Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
Sci Rep, 11 (1), 5127
DOI 10.1038/s41598-021-84695-8, PubMed 33664415

Fronas SG, Jørgensen CT, Dahm AEA, Wik HS, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W (2020)
Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis
Blood Adv, 4 (20), 5002-5010
DOI 10.1182/bloodadvances.2020002173, PubMed 33057634

Hannevik TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2020)
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
Thromb Res, 196, 238-244
DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178

Berentsen S, Barcellini W, D'Sa S, Randen U, Tvedt THA, Fattizzo B, Haukås E, Kell M, Brudevold R, Dahm AEA, Dalgaard J, Frøen H, Hallstensen RF, Jæger PH, Hjorth-Hansen H, Małecka A, Oksman M, Rolke J, Sekhar M, Sørbø JH, Tjønnfjord E, Tsykunova G, Tjønnfjord GE (2020)
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Blood, 136 (4), 480-488
DOI 10.1182/blood.2020005674, PubMed 32374875

Fronas SG, Dahm AEA, Wik HS, Jørgensen CT, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W (2020)
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis
Blood Adv, 4 (11), 2468-2476
DOI 10.1182/bloodadvances.2020001556, PubMed 32502267

Dahm AEA, Jacobsen EM, Wik HS, Jacobsen AF, Mollnes TE, Kanse SM, Sandset PM (2019)
Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis
Thromb Haemost, 119 (9), 1481-1488
DOI 10.1055/s-0039-1692426, PubMed 31254974

Eilertsen AL, Dahm AEA, Høibraaten E, Lofthus CM, Mowinckel MC, Sandset PM (2019)
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
Blood Coagul Fibrinolysis, 30 (1), 17-23
DOI 10.1097/MBC.0000000000000784, PubMed 30507711

Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W (2018)
Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies
J Thromb Haemost, 16 (12), 2471-2481
DOI 10.1111/jth.14314, PubMed 30303610

Kostovski E, Frigato E, Savikj M, Dahm A, Sandset PM, Mowinckel MC, Skretting G, Østerud B, Bertolucci C, Iversen PO (2018)
Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
Spinal Cord, 56 (11), 1076-1083
DOI 10.1038/s41393-018-0176-x, PubMed 29985456

Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA (2018)
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
J Med Case Rep, 12 (1), 105
DOI 10.1186/s13256-018-1663-6, PubMed 29685167

Panagopoulos I, Gorunova L, Andersen HK, Bergrem A, Dahm A, Andersen K, Micci F, Heim S (2018)
PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia
Exp Hematol Oncol, 7, 7
DOI 10.1186/s40164-018-0099-4, PubMed 29560286

Utne KK, Dahm A, Wik HS, Jelsness-Jørgensen LP, Sandset PM, Ghanima W (2018)
Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
Thromb Res, 163, 6-11
DOI 10.1016/j.thromres.2018.01.013, PubMed 29324334

Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM (2017)
A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
Thromb Res, 157, 111-116
DOI 10.1016/j.thromres.2017.07.013, PubMed 28734156

Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
PLoS One, 12 (5), e0176527
DOI 10.1371/journal.pone.0176527, PubMed 28464042

Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
PLoS One, 11 (3), e0152114
DOI 10.1371/journal.pone.0152114, PubMed 26999742

Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
J Thromb Haemost, 14 (2), 387-96
DOI 10.1111/jth.13206, PubMed 26598923

Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE (2015)
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
Arterioscler Thromb Vasc Biol, 36 (2), 418-24
DOI 10.1161/ATVBAHA.115.306905, PubMed 26681757

Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
DOI 10.1097/QAI.0000000000000784, PubMed 26258571

Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
Thromb Haemost, 114 (5), 964-8
DOI 10.1160/TH15-05-0396, PubMed 26202881

Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
Spinal Cord, 53 (4), 285-90
DOI 10.1038/sc.2014.243, PubMed 25644388

Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
J Thromb Haemost, 13 (3), 409-13
DOI 10.1111/jth.12817, PubMed 25495894

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BMC Cancer, 14, 845
DOI 10.1186/1471-2407-14-845, PubMed 25407022

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
DOI 10.1378/chest.13-2828, PubMed 25180723

Kristiansen A, Brandt L, Berge E, Dahm AE, Halvorsen S, Sandset PM, Vandvik PO (2014)
[New guidelines for antithrombotic therapy and thromboprophylaxis]
Tidsskr Nor Laegeforen, 134 (9), 921-2
DOI 10.4045/tidsskr.13.1582, PubMed 24828713

Jacobsen EM, Dahm AE, Vartdal T, Sandset PM (2014)
[Anticoagulation for venous thrombosis and internal diseases]
Tidsskr Nor Laegeforen, 134 (9), 924
DOI 10.4045/tidsskr.13.1597, PubMed 24828715

Dahm AE (2013)
[Estrogen supplements and research paradigms]
Tidsskr Nor Laegeforen, 133 (11), 1210-2
DOI 10.4045/tidsskr.13.0082, PubMed 23759784

Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Thromb Haemost, 109 (4), 606-13
DOI 10.1160/TH12-10-0771, PubMed 23407778

Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
Thromb Haemost, 108 (6), 1165-71
DOI 10.1160/TH12-05-0350, PubMed 23015030

Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
Mol Biol Rep, 39 (12), 10089-96
DOI 10.1007/s11033-012-1882-7, PubMed 22932941

Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
Br J Haematol, 157 (6), 753-61
DOI 10.1111/j.1365-2141.2012.09121.x, PubMed 22533697

Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
Thromb Res, 130 (1), 45-51
DOI 10.1016/j.thromres.2011.12.009, PubMed 22217510

Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
Blood Coagul Fibrinolysis, 22 (4), 254-9
DOI 10.1097/MBC.0b013e3283442ce2, PubMed 21297449

Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
Br J Haematol, 154 (2), 241-7
DOI 10.1111/j.1365-2141.2011.08712.x, PubMed 21564075

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090

Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
J Thromb Haemost, 8 (11), 2443-9
DOI 10.1111/j.1538-7836.2010.04038.x, PubMed 20735725

Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
Mechanisms of thrombosis related to hormone therapy
Thromb Res, 123 Suppl 2, S70-3
DOI 10.1016/S0049-3848(09)70015-5, PubMed 19217481

van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2007)
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
J Thromb Haemost, 6 (2), 346-51
DOI 10.1111/j.1538-7836.2008.02863.x, PubMed 18067603

Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
BMC Cardiovasc Disord, 6, 40
DOI 10.1186/1471-2261-6-40, PubMed 17029634

Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
Br J Haematol, 132 (3), 333-8
DOI 10.1111/j.1365-2141.2005.05876.x, PubMed 16409298

Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2005)
Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
Thromb Res, 118 (2), 281-7
DOI 10.1016/j.thromres.2005.07.021, PubMed 16139333

de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
Determinants of the APTT- and ETP-based APC sensitivity tests
J Thromb Haemost, 3 (7), 1488-94
DOI 10.1111/j.1538-7836.2005.01430.x, PubMed 15978106

Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
J Thromb Haemost, 3 (4), 651-8
DOI 10.1111/j.1538-7836.2005.01237.x, PubMed 15842349

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
Blood, 101 (11), 4387-92
DOI 10.1182/blood-2002-10-3188, PubMed 12560220

Dahm AE, Brørs O (2002)
[Phenytoin poisoning caused by interaction with ticlopidine]
Tidsskr Nor Laegeforen, 122 (3), 278-80
PubMed 11894596

Blomhoff S, Jacobsen MB, Spetalen S, Dahm A, Malt UF (2000)
Perceptual hyperreactivity to auditory stimuli in patients with irritable bowel syndrome
Scand J Gastroenterol, 35 (6), 583-9
DOI 10.1080/003655200750023534, PubMed 10912657

Review articles

Storlien T, Dahm AEA (2023)
[Not Available]
Tidsskr Nor Laegeforen, 143 (15)
DOI 10.4045/tidsskr.22.0490, PubMed 37874067

Dahm AEA (2021)
Cancer and Thrombosis: New Treatments, New Challenges
Med Sci (Basel), 9 (2)
DOI 10.3390/medsci9020041, PubMed 34204957

Friis Berntsen C, Rootwelt P, Dahm AEA (2021)
Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta-analysis
Res Pract Thromb Haemost, 5 (4), e12507
DOI 10.1002/rth2.12507, PubMed 34013151

Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
Angiogenesis and hemostasis in hematological neoplasias
Curr Drug Targets, 6 (6), 683-99
DOI 10.2174/1389450054863699, PubMed 16178801

Other articles

Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0228, PubMed 36655971

Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
J Thromb Haemost, 20 (8), 1937-1939
DOI 10.1111/jth.15774, PubMed 35859282

Dahm AEA, Sandset PM (2021)
Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
Blood Adv, 5 (11), 2516-2517
DOI 10.1182/bloodadvances.2021004651, PubMed 34086862

Sandset PM, Dahm AEA (2019)
Is venous thromboembolism a problem in patients with cancer in palliative care?
Lancet Haematol, 6 (2), e61-e62
DOI 10.1016/S2352-3026(18)30218-7, PubMed 30709433

Dahm AE, Ghanima W (2017)
[New direct-acting anticoagulants for cancer patients?]
Tidsskr Nor Laegeforen, 137 (3), 171-172
DOI 10.4045/tidsskr.17.0008, PubMed 28181748

Dahm A (2013)
[A. Dahm replies]
Tidsskr Nor Laegeforen, 133 (16), 1687
DOI 10.4045/tidsskr.13.1020, PubMed 24005699

Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
J Thromb Haemost, 8 (5), 1130-2
DOI 10.1111/j.1538-7836.2010.03805.x, PubMed 20149077

Dahm AE, Sandset PM, Rosendaal FR (2007)
The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
J Thromb Haemost, 6 (2), 393-5
DOI 10.1111/j.1538-7836.2008.02859.x, PubMed 18045239

Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
J Thromb Haemost, 4 (8), 1840-2
DOI 10.1111/j.1538-7836.2006.02048.x, PubMed 16879232

Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
J Clin Oncol, 24 (17), 2683-4; author reply 2684
DOI 10.1200/JCO.2006.06.4345, PubMed 16763285

Theses

Dahm AEA (2006)
Tissue factor pathway inhibitor: circadian variation, risk of deep-vein thrombosis, and interaction with oestrogen receptor ligands
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 439, 1 b. (flere pag.)
BIBSYS 061836834, ISBN 82-8080-172-3